Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Nov;6(Suppl 1):S36.
doi: 10.21037/atm.2018.09.42.

We should not avoid diclofenac in the treatment of spondyloarthritis

Affiliations
Editorial

We should not avoid diclofenac in the treatment of spondyloarthritis

Gerhard Zingler et al. Ann Transl Med. 2018 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

Similar articles

References

    1. Dubreuil M, Louie-Gao Q, Peloquin CE, et al. Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis. Ann Rheum Dis 2018;77:1137-42. - PMC - PubMed
    1. Sangha O. Epidemiology of rheumatic diseases. Rheumatology (Oxford) 2000;39 Suppl 2:3-12. 10.1093/rheumatology/39.suppl_2.3 - DOI - PubMed
    1. Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 2000;343:1520-8. 10.1056/NEJM200011233432103 - DOI - PubMed
    1. Zingler G, Hermann B, Fischer T, et al. Cardiovascular adverse events by non-steroidal anti-inflammatory drugs: when the benefits outweigh the risks. Expert Rev Clin Pharmacol 2016;9:1479-92. 10.1080/17512433.2016.1230495 - DOI - PubMed
    1. Lauper K, Gabay C. Cardiovascular risk in patients with rheumatoid arthritis. Semin Immunopathol 2017;39:447-59. 10.1007/s00281-017-0632-2 - DOI - PubMed